Xphozah 30 MG
Ended Awarded Last action
- Contract number
- 36C24526N0497
- Awardee
-
Ardelyx, Inc. UEI YLYTCEN9K617
- Awarding agency
-
Veterans Integrated Service Network 5
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $1,991
Award facts
- Contract value 100% obligated
- $1,991.36 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Dublin, OH 43017, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, awarded to Ardelyx, Inc. on April 9, 2026, represents a $1,991.36 procurement of XPHOZAH 30 mg tablets for the Department of Veterans Affairs' Veterans Integrated Service Network 5 (VISN 5). The award utilizes a firm fixed-price delivery order structure under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) and carries an ultimate completion date of April 14, 2026. The contract was awarded without socioeconomic set-aside designation, indicating open competition. The place of performance is Dublin, Ohio, which supports VA medical centers in the VISN 5 region. This delivery order is part of Ardelyx's ongoing pharmaceutical supply relationship with the VA, which provides XPHOZAH, a specialized medication designed to treat hyperphosphatemia in dialysis patients—a significant clinical need within the veteran population with chronic kidney disease.
This award is issued under a $32.5 million Blanket Purchase Agreement that Ardelyx received from the National Acquisition Center on April 30, 2024, under the Pharmaceuticals and Drugs Federal Supply Schedule, which serves as the parent indefinite delivery vehicle for multiple delivery orders across various Veterans Integrated Service Networks. Ardelyx, a for-profit pharmaceutical company headquartered in Fremont, California, has established itself as a key supplier to the VA since its SAM.gov registration in December 2011. The company maintains additional Federal Supply Schedule authority through a separate contract with VISN 12 valued at $300,000, enabling efficient distribution of this specialized hyperphosphatemia treatment to veterans nationwide across multiple geographic locations.
Quick answers
Who was awarded contract 36C24526N0497?
36C24526N0497 was awarded to Ardelyx, Inc. by Veterans Integrated Service Network 5 (Veterans Health Administration) on April 9, 2026.
How much is contract 36C24526N0497 worth?
The government has obligated $1,991 on 36C24526N0497.
Is contract 36C24526N0497 an order under another contract?
Yes. 36C24526N0497 is a delivery order under 36F79722D0165, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24526N0497 competed?
The extent of competition for 36C24526N0497 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award